News | Coronavirus (COVID-19) | May 18, 2023

Infarction Growth, Penumbral Consumption After Reperfusion in COVID Vaccine-Naïve Patients

SARS-CoV-2 infection may promote continued infarction progression, despite angiographic reperfusion, in vaccine-naïve patients with large-vessel occlusion acute ischemic stroke 

54-year-old patient with COVID-19 who underwent full angiographic reperfusion (extended thrombolysis in cerebral ischemia score = 3) after acute ischemic stroke. Top: Automated readout summary of CT perfusion data at presentation shows large mismatch volume (54 mL). Bottom: Follow-up MR image shows progression in infarction growth, with final infarction volume of approximately 72 cm3 (600% increase from CT perfusion imaging estimate of 9 mL shown in A). 

54-year-old patient with COVID-19 who underwent full angiographic reperfusion (extended thrombolysis in cerebral ischemia score = 3) after acute ischemic stroke. Top: Automated readout summary of CT perfusion data at presentation shows large mismatch volume (54 mL). Bottom: Follow-up MR image shows progression in infarction growth, with final infarction volume of approximately 72 cm3 (600% increase from CT perfusion imaging estimate of 9 mL shown in A). 


May 18, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), SARS-CoV-2 infection may promote continued infarction progression, despite angiographic reperfusion, in vaccine-naïve patients with large-vessel occlusion acute ischemic stroke (AIS).   

“The findings carry potential implications for prognostication, treatment selection, and surveillance for infarction growth among revascularized patients in future waves of infection by novel viral strains,” wrote first author Seena Dehkharghani, MD, director of stroke and cerebrovascular imaging at New York University Langone Medical Center

This AJR accepted manuscript compared 100 consecutively presenting patients with COVID-19 and AIS between March 2020 and April 2021 with a contemporaneous cohort of 282 patients with AIS who did not have COVID-19. Reperfusion classes were dichotomized into positive (extended thrombolysis in cerebral ischemia [eTICI] score = 2c–3) and negative (eTICI score < 2c) groups. All patients underwent endovascular therapy following initial CT perfusion imaging (CTP) to document infarction core and total hypoperfusion volumes. 

Ultimately, in this case-control study of vaccine-naïve patients with and without COVID-19 with infarct growth after endovascular reperfusion during acute ischemic stroke, COVID-19 was a significant predictor for absolute infarct growth of 15 cm3 or more (OR, 5.1 [95% CI, 1.0–25.95]; p = .05). 

“These findings support the potentially aggressive clinical course of cerebrovascular events in patients with COVID-19, suggesting greater infarction growth and ongoing consumption of at-risk tissues, even following angiographic reperfusion,” Dehkharghani et al. added. 

For more information: www.arrs.org 

Find more ARRS news here


Related Content

News | Coronavirus (COVID-19)

October 16, 2023 — A door-to-balloon (D2B) time of 90-minutes or less is associated with improved outcomes for heart ...

Home October 16, 2023
Home
News | Coronavirus (COVID-19)

October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications ...

Home October 11, 2023
Home
News | Coronavirus (COVID-19)

September 26, 2023 — New research from the Smidt Heart Institute at Cedars-Sinai shows that patients who went to a ...

Home September 26, 2023
Home
News | Coronavirus (COVID-19)

June 19, 2023 — Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to ...

Home June 19, 2023
Home
News | Coronavirus (COVID-19)

June 14, 2023 — A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies ...

Home June 14, 2023
Home
News | Coronavirus (COVID-19)

June 9, 2023 — Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID ...

Home June 09, 2023
Home
News | Coronavirus (COVID-19)

May 31, 2023 — Cytomegalovirus (CMV) is one of the most prevalent herpesviruses worldwide. Depending on the geographical ...

Home May 31, 2023
Home
News | Coronavirus (COVID-19)

May 10, 2023 — A small randomized trial in patients with post-COVID syndromehas found that hyperbaric oxygen therapy ...

Home May 10, 2023
Home
News | Coronavirus (COVID-19)

April 27, 2023 — New research suggests that even mild cases of COVID-19 can have long-term detrimental effects on ...

Home April 27, 2023
Home
News | Coronavirus (COVID-19)

April 27, 2023 — Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has ...

Home April 27, 2023
Home
Subscribe Now